Priority Research Papers:
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation
Metrics: PDF 655 views | HTML 1221 views | ?
Aejaz Sayeed1,2, Huimin Lu1,2, Qin Liu1,3, David Deming II1,2, Alexander Duffy1,2, Peter McCue4, Adam P. Dicker5, Roger J. Davis6,7, Dmitry Gabrilovich1,8, Ulrich Rodeck5,9, Dario C. Altieri1,10 and Lucia R. Languino1,2,5
1 Prostate Cancer Discovery and Development Program, Philadelphia, PA, USA
2 Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA
3 Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA
4 Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA
5 Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA
6 Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA
7 Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA, USA
8 Translational Tumor Immunology Program, The Wistar Institute, Philadelphia, PA, USA
9 Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA
10 Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA
Lucia R. Languino, email:
Keywords: TRAMP mice, prostate cancer, β1 integrins, FAK, insulin-like growth factor receptor
Received: November 25, 2015 Accepted: June 15, 2016 Published: July 11, 2016
Radiation therapy is an effective cancer treatment modality although tumors invariably become resistant. Using the transgenic adenocarcinoma of mouse prostate (TRAMP) model system, we report that a hypofractionated radiation schedule (10 Gy/day for 5 consecutive days) effectively blocks prostate tumor growth in wild type (β1wt /TRAMP) mice as well as in mice carrying a conditional ablation of β1 integrins in the prostatic epithelium (β1pc-/- /TRAMP). Since JNK is known to be suppressed by β1 integrins and mediates radiation-induced apoptosis, we tested the effect of SP600125, an inhibitor of c-Jun amino-terminal kinase (JNK) in the TRAMP model system. Our results show that SP600125 negates the effect of radiation on tumor growth in β1pc-/- /TRAMP mice and leads to invasive adenocarcinoma. These effects are associated with increased focal adhesion kinase (FAK) expression and phosphorylation in prostate tumors in β1pc-/- /TRAMP mice. In marked contrast, radiation-induced tumor growth suppression, FAK expression and phosphorylation are not altered by SP600125 treatment of β1wt /TRAMP mice. Furthermore, we have reported earlier that abrogation of insulin-like growth factor receptor (IGF-IR) in prostate cancer cells enhances the sensitivity to radiation. Here we further explore the β1/IGF-IR crosstalk and report that β1 integrins promote cell proliferation partly by enhancing the expression of IGF-IR. In conclusion, we demonstrate that β1 integrin-mediated inhibition of JNK signaling modulates tumor growth rate upon hypofractionated radiation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.